✦ LIBER ✦

Oral Vinorelbine Plus Cisplatin as First-Line Chemotherapy in Nonsquamous Non–Small-Cell Lung Cancer: Final Results of an International Randomized Phase II Study (NAVotrial 01)

✍ Scribed by Bennouna, Jaafar; Havel, Libor; Krzakowski, Maciej; Kollmeier, Jens; Gervais, Radj; Dansin, Eric; Serke, Monika; Favaretto, Adolfo; Szczesna, Aleksandra; Cobo, Manuel; Ciuffreda, Libero; Jassem, Jacek; Nicolini, Mario; Ramlau, Rodryg; Amoroso, Domenico; Melotti, Barbara; Almodovar, Teresa; Riggi, Marcello; Caux, Noël-Raphaël; Vaissière, Nathalie; Tan, Eng-Huat

Book ID: 122336120
Publisher: CIG Media Group, LP.
Year: 2014
Tongue: English
Weight: 145 KB
Volume: 15
Category: Article
ISSN: 1525-7304
DOI: 10.1016/j.cllc.2014.04.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of Gemcitabine, Ifosfamid

Phase II study of Gemcitabine, Ifosfamide plus Vinorelbine (GIN) as a first-line chemotherapy in advanced non-small cell lung cancer (NSCLC): A promising non-cisplatin based regimen

✍ Castellano, D; Lianes, P; Arcediano, A; Gómez-Martin, C; Ciruelos, E; Bezares, S 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Hybrid (intravenous and oral) administra

Hybrid (intravenous and oral) administration of vinorelbine plus cisplatinum followed by oral vinorelbine as first-line therapy of advanced non-small cell lung cancer: A phase II study

✍ Martoni, A.A.; Melotti, B.; Sperandi, F.; Giaquinta, S.; Piana, E.; Pavesi, L.; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Randomized phase 2 study of irinotecan p

Randomized phase 2 study of irinotecan plus cisplatin versus gemcitabine plus vinorelbine as first-line chemotherapy with second-line crossover in patients with advanced nonsmall cell lung cancer

✍ Ji-Youn Han; Dae Ho Lee; Jung Eun Song; Sung Young Lee; Hyae Young Kim; Heung Ta 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB 👁 1 views

Phase II study of liposomal cisplatin (L

Phase II study of liposomal cisplatin (Lipoplatin™) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer

✍ Mylonakis, N.; Athanasiou, A.; Ziras, N.; Angel, J.; Rapti, A.; Lampaki, S.; Pol 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 506 KB

A randomized phase II study of recombina

A randomized phase II study of recombinant human endostatin plus gemcitabine/cisplatin compared with gemcitabine/cisplatin alone as first-line therapy in advanced non-small-cell lung cancer

✍ Xin Zhao, Kai Mei, Xiaohong Cai, Jing Chen, Jingrui Yu, Chengya Zhou, Qiu Li 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 136 KB

nCombination chemotherapy with docetaxel

nCombination chemotherapy with docetaxel, vinorelbine and cisplatin as first-line treatment of advanced non-small-cell lung cancer: A multicenter phase II study of the Greek Cooperative Group for Lung Cancer

✍ Georgoulias, Vassilis; Androulakis, Nikos; Bouros, Demosthenis; Kouroussis, Char 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 87 KB